A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yiming,Qin

第一单位： Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

作者： Yiming,Qin ^[1] ; Xiongbing,Zu ^[2] ; Yin,Li ^[3] ; Ying,Han ^[3] ; Jun,Tan ^[4] ; Changjing,Cai ^[3] ; Edward,Shen ^[5] ; Ping,Liu ^[3] ; Ganlu,Deng ^[6] ; Ziyang,Feng ^[3] ; Wantao,Wu ^[3] ; Yinghui,Peng ^[3] ; Yongting,Liu ^[3] ; Jiayao,Ma ^[3] ; Shan,Zeng ^[3] ; Yihong,Chen ^[2] ; Hong,Shen ^[3]

作者单位： Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. ^[1] National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. ^[2] Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. ^[3] Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. ^[4] Department of Life Science, McMaster University, Hamilton L8S 4L8, ON, Canada. ^[5] Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530022, Guangxi, China. ^[6]

关键词 Cancer Oncology Transcriptomics

DOI 10.1016/j.isci.2023.107722

PMID 37694141

发布时间 2023-09-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

iScience

2023年26卷9期

107722页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

iScience

相似文献

iScience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

iScience

相似文献

iScience

相关期刊

检索历史清除